Page last updated: 2024-09-04

olmesartan and Hyperpotassemia

olmesartan has been researched along with Hyperpotassemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garland, K; Rishi, A1
Chan, JC; Haneda, M; Imai, E; Ito, S; Kobayashi, F; Makino, H; Yamasaki, T1

Trials

1 trial(s) available for olmesartan and Hyperpotassemia

ArticleYear
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study.
    Diabetologia, 2011, Volume: 54, Issue:12

    Topics: Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Asian People; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Hypertension; Imidazoles; Kidney Failure, Chronic; Male; Middle Aged; Proteinuria; Stroke; Tetrazoles; Treatment Outcome

2011

Other Studies

1 other study(ies) available for olmesartan and Hyperpotassemia

ArticleYear
Unusual Severe Side Effect of a Commonly Used Drug.
    Journal of clinical hypertension (Greenwich, Conn.), 2016, Volume: 18, Issue:4

    Topics: Aged; Antihypertensive Agents; Blood Pressure; Humans; Hyperkalemia; Hypertension; Imidazoles; Male; Severity of Illness Index; Tetrazoles

2016